Authors: SCHIERL R ROHRER B HOHNLOSER J

Citation: R. Schierl et al., LONG-TERM PLATINUM EXCRETION IN PATIENTS TREATED WITH CISPLATIN, Cancer chemotherapy and pharmacology, 36(1), 1995, pp. 75-78

Authors: BOKEMEYER C SCHMOLL HJ HARSTRICK A ILLIGER HJ METZNER B RATH U HOHNLOSER J CLEMM C BERDEL W SIEGERT W RUTHER U OSTERMANN H KNEBA M HARTLAPP JH SCHRODER M POLIWODA H

Citation: C. Bokemeyer et al., A PHASE I II STUDY OF A STEPWISE DOSE-ESCALATED REGIMEN OF CISPLATIN,ETOPOSIDE AND IFOSFAMIDE PLUS GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) IN PATIENTS WITH ADVANCED GERM-CELL TUMORS/, European journal of cancer, 29A(16), 1993, pp. 2225-2231

Authors: HEHLMANN R HEIMPEL H HASFORD J KOLB HJ PRALLE H HOSSFELD DK QUEISSER W LOFFLER H HEINZE B GEORGII A VONWUSSOW P BARTRAM C GRIESSHAMMER M BERGMANN L ESSERS U FALGE C HOCHHAUS A QUEISSER U SICK C MEYER P SCHMITZ N VERPOORT K EIMERMACHER H WALTHER F WESTERHAUSEN M KLEEBERG UR HEILEIN A KABISCH A BARZ C ZIMMERMANN R MEURET G TICHELLI A BERDEL WE KANZ L ANGER B TIGGES FJ SCHMID L BROCKHAUS W ZANKOVICH R SCHLAFER U WEISSENFELS I MAINZER K TOBLER A PERKER M HOHNLOSER J MESSENER D THIELE J BUHR T ANSARI H

Citation: R. Hehlmann et al., RANDOMIZED COMPARISON OF BUSULFAN AND HYDROXYUREA IN CHRONIC MYELOGENOUS LEUKEMIA - PROLONGATION OF SURVIVAL BY HYDROXYUREA, Blood, 82(2), 1993, pp. 398-407